LADENBURG THALMANN FINANCIAL SERVICES INC. - HEMISPHERX BIOPHARMA INC ownership

HEMISPHERX BIOPHARMA INC's ticker is HEB and the CUSIP is 42366C301. A total of 19 filers reported holding HEMISPHERX BIOPHARMA INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
LADENBURG THALMANN FINANCIAL SERVICES INC. ownership history of HEMISPHERX BIOPHARMA INC
ValueSharesWeighting
Q1 2019$02,080
+92.6%
0.00%
Q4 2018$01,0800.0%0.00%
Q3 2018$01,0800.0%0.00%
Q2 2018$01,0800.0%0.00%
Q1 2018$01,080
+1250.0%
0.00%
Q4 2017$0800.0%0.00%
Q3 2017$0800.0%0.00%
Q2 2017$0800.0%0.00%
Q1 2017$0800.0%0.00%
Q4 2016$0800.0%0.00%
Q3 2016$0800.00%
Other shareholders
HEMISPHERX BIOPHARMA INC shareholders Q1 2019
NameSharesValueWeighting ↓
Anson Funds Management LP 1,071,627$739,0000.23%
SABBY MANAGEMENT, LLC 1,391,286$960,0000.06%
Occidental Asset Management, LLC 15,834$11,0000.01%
Waldron Private Wealth LLC 11,000$7,0000.00%
LADENBURG THALMANN FINANCIAL SERVICES INC. 80$00.00%
BLACKROCK ADVISORS LLC 5,727$4,0000.00%
UBS Group AG 10,200$7,0000.00%
CITY HOLDING CO 417$00.00%
NORTHERN TRUST CORP 17,111$11,0000.00%
GEODE CAPITAL MANAGEMENT, LLC 74,832$51,0000.00%
View complete list of HEMISPHERX BIOPHARMA INC shareholders